7 Causes of Anisocytosis and What They Mean for Your Blood

Anisocytosis is a blood finding that means red blood cells are not all the same size. Instead of appearing fairly uniform, some red blood cells may be smaller than normal, larger than normal, or mixed in size. Doctors often notice anisocytosis through a complete blood count, especially when the red cell distribution width, or RDW, is higher than expected. While anisocytosis is not a disease by itself, it can offer important clues about what may be affecting the blood.

Understanding the causes of anisocytosis can help explain why a person may feel tired, weak, short of breath, dizzy, or unusually pale. In many cases, it is linked to anemia, nutritional deficiencies, blood loss, chronic illness, bone marrow problems, or recovery after treatment. The meaning depends on other test results, such as hemoglobin, MCV, iron studies, vitamin B12, folate, and the appearance of blood cells under a microscope. This article explores seven causes of anisocytosis and what they may reveal about your blood.

What is Anisocytosis and Why is Red Blood Cell Size Important?

Anisocytosis is the medical term for a condition in which a person’s red blood cells (erythrocytes) are of unequal size, a finding that is significant because the uniform size and shape of these cells are critical for their primary function of efficient oxygen transport throughout the body. This variation is an important diagnostic marker that signals an underlying issue with red blood cell production or maturation.

To understand better, it is essential to first grasp the characteristics of a healthy red blood cell and how deviations are measured.

1. Erythrocyte Structural Dynamics and Functional Requirements

The anisocytosis meaning describes an optical and quantitative variation in red blood cell volume. To understand why this structural variance is flagged as an anisocytosis abnormal finding, it is necessary to examine the strict engineering of a healthy red blood cell (erythrocyte).

In a healthy individual, mature red blood cells are uniform in size, maintaining a diameter of 7 to 8 micrometers and a thickness of approximately 2 micrometers.

                       [Healthy Erythrocyte Anatomy]
                                     │
      ┌──────────────────────────────┴──────────────────────────────┐
      ▼                                                             ▼
[Biconcave Disk Morphology]                            [High Deformability Membrane]
- Flattened center maximizes surface-to-volume ratio   - Flexible skeleton bends without bursting
- Speeds up gas diffusion in lungs & tissues          - Squeezes through 4-micrometer capillaries
- Packages ~270 million hemoglobin units               - Prevents vascular friction and blockages

Rather than a simple sphere, a healthy erythrocyte is formed as a flexible biconcave disc—resembling a doughnut with a thin, unpierced center. This shape increases the cell’s surface-area-to-volume ratio, which maximizes the rate of gas exchange. This structural design allows for the rapid loading of oxygen in the lungs and its smooth release into peripheral tissues.

The cytoplasm of each individual cell is packed with roughly 270 million molecules of hemoglobin, an iron-rich protein that binds oxygen. This uniform sizing ensures that each cell carries a predictable amount of hemoglobin, stabilizing the body’s overall oxygen-carrying capacity.

Furthermore, this biconcave shape combined with a flexible cell membrane gives the erythrocyte high deformability. This allows it to bend, twist, and squeeze through tight capillary networks as narrow as 4 micrometers in diameter without bursting. When an anisocytosis abnormal state disrupts this uniform design, the physical flow of blood and the efficiency of oxygen delivery are compromised.

2. Laboratory Quantification and Automated Diagnostics

An automated Complete Blood Count (CBC) is the primary method used to identify and measure an anisocytosis abnormal state. While standard hematology markers like hemoglobin indicate the total volume of red blood cells, they do not show variations in individual cell size.

[Automated CBC Analysis] ──► Calculates Volume Deviation ──► Elevates RDW % ──► Flags Anisocytosis

To calculate this variance, laboratory analyzers evaluate a specific metric known as the Red Cell Distribution Width (RDW). The RDW provides a statistical percentage representing the standard deviation of red blood cell volume.

A normal, healthy RDW falls between 11.5% and 15.0%. When a patient’s RDW rises above 15.0%, it serves as the definitive laboratory marker for anisocytosis, proving that the bone marrow is releasing a mismatched population of red blood cells.

Clinical Matrix: Combining RDW and MCV

To determine the specific cause behind an anisocytosis meaning, physicians interpret an elevated RDW alongside the Mean Corpuscular Volume (MCV), which measures the average size of the red blood cells.

7 Primary Causes of Anisocytosis

The seven primary causes of anisocytosis include iron deficiency anemia, vitamin B12 or folate deficiency, thalassemia, myelodysplastic syndromes, chronic liver disease or alcoholism, recent blood transfusions, and the effects of chemotherapy. Each of these conditions disrupts the normal, regulated production of red blood cells in the bone marrow, leading to significant variations in their size. Next, we will explore how each of these distinct medical situations leads to this hematological finding.

1. Microcytic Etiologies: Iron Deficiency and Thalassemia

When a Complete Blood Count (CBC) flags an anisocytosis abnormal result alongside a low Mean Corpuscular Volume (MCV), it indicates microcytic anisocytosis. In this state, the bone marrow produces red blood cells that are both smaller than normal and highly variable in size. This presentation is primarily driven by iron deficiency anemia and genetic thalassemia traits.

                      [Microcytic Anisocytosis Pathways]
                                       │
       ┌───────────────────────────────┴───────────────────────────────┐
       ▼                                                               ▼
[Iron Deficiency State]                                     [Genetic Thalassemia Trait]
- Erythroblasts undergo extra divisions                     - Defective globin chain synthesis occurs
- New cells become progressively smaller                    - Excess globin chains precipitate in marrow
- Mixes older normocytes with small microcytes              - Releases damaged, irregular cell shapes

Iron Deficiency Anemia

Iron is a fundamental building block required to manufacture hemoglobin. When the body’s iron stores are depleted, the bone marrow lacks the raw materials needed to fill developing red blood cell precursors (erythroblasts). To compensate, these precursor cells undergo extra cell divisions before maturing, which results in smaller cells called microcytes.

The anisocytosis meaning becomes apparent due to the gradual nature of this deficiency. In the early stages, residual iron allows for the production of normal-sized cells. As iron levels drop further, newly released cells become progressively smaller.

This creates a split population in the bloodstream: older, normal-sized cells mixed with newer, microcytic cells. This structural variation causes a high Red Cell Distribution Width (RDW).

Thalassemia

Thalassemia is an inherited genetic disorder characterized by a reduced or absent synthesis of the alpha or beta-globin chains that make up hemoglobin. This production imbalance disrupts the formation of stable hemoglobin molecules.

The excess, unpaired globin chains precipitate inside red blood cell precursors within the bone marrow, destroying many of them before they can mature. The cells that do survive and enter the circulation are poorly hemoglobinized, making them small (microcytic) and pale (hypochromic).

This high-stress production environment causes the marrow to release an irregular population of red blood cells. A peripheral blood smear from a thalassemia patient reveals a distinct mix of cell sizes and shapes, including target cells, teardrop cells, and fragmented cells, which drives up the RDW.

2. Macrocytic Etiologies: Nutritional Deficiencies, Liver Disease, and Chemotherapy

Macrocytic anisocytosis occurs when an elevated RDW is paired with a high MCV, meaning the circulating red blood cells are abnormally large and vary significantly in size. This pattern typically points to impaired DNA synthesis or structural cell membrane defects.

                      [Macrocytic Anisocytosis Pathways]
                                       │
    ┌──────────────────────────────────┼──────────────────────────────────┐
    ▼                                  ▼                                  ▼
[B12 / Folate Deficiency]    [Chronic Liver / Alcoholism]       [Cytotoxic Chemotherapy]
- Halts nuclear thymidine    - Disrupts lipid regulation        - Disrupts stem cell replication
- Cytoplasm grows too large  - Cholesterol warps membranes      - Erratically alters marrow output
- Megaloblastic cells expand - Cells flatten into macrocytes    - Releases large, irregular cells

Vitamin B12 and Folate Deficiencies

Vitamin B12 and folate are essential cofactors for DNA synthesis and cellular division. When these vitamins are lacking, rapidly dividing hematopoietic stem cells in the bone marrow cannot synthesize thymidine, a key building block of DNA.

This creates a state called megaloblastic maturation, where the cell’s nucleus matures much slower than its cytoplasm. The precursor cells continue to grow in size but are unable to divide normally.

The bone marrow then releases these oversized, immature, and fragile cells (macrocytes) into the bloodstream. Because some cells manage to divide while others fail and expand, a highly varied population of cell sizes enters circulation, raising the RDW.

Chronic Liver Disease and Alcoholism

The liver plays a key role in lipid metabolism, including regulating the cholesterol and phospholipids that form the outer shell of red blood cells. In advanced liver disease, such as cirrhosis, this lipid regulation breaks down. Excess cholesterol and lecithin accumulate in the plasma and deposit into the membranes of circulating red blood cells.

This excess lipid expands the surface area of the cell membrane relative to its volume, causing the cells to become larger, flattened macrocytes. Because the amount of lipid loading varies from cell to cell, it creates inconsistent sizes and shapes, such as target cells or spur cells.

Additionally, chronic alcoholism can exert a direct toxic effect on the bone marrow and often leads to secondary folate deficiencies due to poor nutrition and malabsorption, further worsening the macrocytic anisocytosis.

Chemotherapy Agents

Conventional chemotherapy drugs target and destroy rapidly replicating cells. While effective against cancer, these drugs also impact healthy tissues with high cell turnover, particularly the blood-producing stem cells in the bone marrow.

This chemotherapy-induced bone marrow suppression disrupts the orderly process of red blood cell production. These cytotoxic drugs damage DNA synthesis pathways, mimicking a B12 or folate deficiency by preventing normal cell division while allowing cytoplasmic growth.

As the bone marrow attempts to recover between treatment cycles, it releases cells of varying sizes and stages of maturity, resulting in a highly irregular population of circulating red blood cells.

3. Independent Structural Catalyst Groups: Transfusions and MDS

Certain causes of an anisocytosis abnormal finding do not fit neatly into simple nutritional or structural categories. Instead, they represent either a cancerous disruption of bone marrow production or a temporary, medically induced mixture of two separate blood populations.

[Patient's Native Small Microcytes] ──► [Transfusion of Normal Normocytes] ──► Dimorphic Population (High RDW)

Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes represent a group of clonal bone marrow cancers characterized by ineffective hematopoiesis, where blood cells are produced in a disordered and dysfunctional manner. In MDS, mutated hematopoietic stem cells lose the ability to mature into healthy blood components.

This leads to abnormal red blood cell development at every stage. The marrow produces a chaotic population of cells that vary widely in size, shape, and hemoglobin content.

Unlike the more predictable size variations seen in nutritional deficiencies, the anisocytosis in MDS can be quite extreme, showing a simultaneous mix of small, normal, and oversized cells. These cells often display unusual features under a microscope, such as multiple nuclei or iron-laden ring sideroblasts, resulting in a significantly elevated RDW.

Recent Blood Transfusions

A recent blood transfusion is a common, temporary cause of anisocytosis. It introduces a mixed population of red blood cells into the patient’s bloodstream, a state known as dimorphism.

For example, if a patient with severe iron deficiency anemia (whose native red blood cells are small and microcytic) receives a transfusion of packed red blood cells from a healthy donor (whose cells are normal-sized and normocytic), their circulation will immediately contain both cell populations at once.

When a laboratory instrument analyzes this mixed sample, it registers a very high variation in individual cell volumes, resulting in a markedly elevated RDW. This type of anisocytosis is transient and will gradually disappear as the donor cells age and the patient’s underlying anemia is treated.

What Does Anisocytosis Mean for Your Red Blood Cells and Overall Health?

For your red blood cells and overall health, anisocytosis means that the cells are less efficient at transporting oxygen, which can lead to symptoms of anemia; however, its primary significance is as a clinical sign pointing to an underlying medical condition that requires diagnosis and treatment. It is a reflection of a problem in production, not the problem itself.

To understand better, it is important to examine the direct physiological effects of varied cell size and the symptoms that result from the underlying causes.

1. Impairment of Ocular and Microvascular Gas Exchange

An anisocytosis abnormal lab value highlights a structural disruption that reduces the respiratory efficiency of the bloodstream. When red blood cells vary dramatically in size, they lose the ideal biconcave shape optimized for gas diffusion, making oxygen delivery less effective.

                        [Varied Red Blood Cell Volumes]
                                       │
       ┌───────────────────────────────┴───────────────────────────────┐
       ▼                                                               ▼
[Microcytic Volume Reductions]                         [Macrocytic Membrane Fragility]
- Severe hemoglobin packaging deficits                  - Lowered surface-to-volume ratio slowing diffusion
- Reduced total oxygen carrying capacity                - Inflexible cells struggle in tight capillaries
- Drives widespread peripheral hypoxia                  - Higher rates of premature destruction (hemolysis)

In microcytic populations, the individual cells are small because they lack sufficient hemoglobin. Since hemoglobin is the iron-bearing protein that binds oxygen molecules, each microcyte has a severely reduced carrying capacity. This prevents the blood from maintaining an adequate oxygen load, leading to tissue hypoxia.

Conversely, while macrocytic cells are physically larger, they are often less efficient. These oversized cells are frequently structurally unsound, with fragile cell membranes that easily rupture. This structural weakness leads to premature destruction, known as hemolysis, which shortens their lifespan and reduces the total number of circulating red blood cells.

Furthermore, their larger, rounder shape decreases the surface-area-to-volume ratio, slowing down the diffusion of gases across the membrane. Their rigid structure also makes it difficult for them to navigate narrow, 4-micrometer capillaries, which can impede blood flow to vital organs.

2. Clinical Symptom Matrix of Systemic Hypoxia

The symptoms associated with an anisocytosis meaning do not stem from the size variation itself, but rather from the systemic oxygen shortage caused by the underlying disease. When the body’s tissues are starved of oxygen, a predictable set of symptoms develops.

[Deficient Oxygen Delivery] ──► Tissue Hypoxia ──► Systemic Compensatory Fatigue & Exertional Dyspnea

• Persistent Fatigue and Lethargy: Chronic weakness occurs because the brain and skeletal muscles lack the oxygen required to fuel cellular metabolism and meet daily energy demands.

• Exertional Dyspnea (Shortness of Breath): As oxygen carrying capacity drops, the respiratory and cardiovascular systems work overtime. This causes breathlessness during minor physical activities as the lungs strain to maximize gas intake.

• Widespread Mucocutaneous Pallor: A noticeable paleness can be observed in the conjunctiva of the eyes, nail beds, and palms, reflecting a lower concentration of bright red, oxygenated hemoglobin in the superficial blood vessels.

• Peripheral Vasoconstriction: Patients often experience cold hands and feet as the sympathetic nervous system redirects oxygen-rich blood flow away from the extremities to protect vital internal organs.

• Cardiovascular Palpitations: In severe cases, the heart must beat faster and contract harder to circulate the compromised blood volume, leading to an irregular heartbeat, racing sensations, and potential chest strain.

3. Pathological Classification: Diagnostic Sign vs. Active Disease

It is clinically vital to recognize that anisocytosis abnormal findings do not represent an independent disease. Instead, anisocytosis is an objective laboratory marker or clinical sign indicating a disruption in the production of red blood cells within the bone marrow.

                  [The Clinical Context of Anisocytosis]
                                     │
     ┌───────────────────────────────┴───────────────────────────────┐
     ▼                                                               ▼
[The Diagnostic Analogy]                        [The Clinical Investigation]
- Acts exactly like a fever                     - Serves as a red flag for marrow production
- Signifies systemic irritation                 - Triggers targeted tests for the root cause
- Treating the sign alone fixes nothing         - Resolves naturally once the disease is managed

Equating anisocytosis to an independent illness is like viewing a fever as a complete diagnosis. A fever is an overlapping clinical response that warns a physician of an underlying infection or inflammatory process, but it is not the disease itself.

In the same way, an elevated RDW or a varied blood smear acts as a red flag signaling a breakdown in erythropoiesis—the production and maturation of red blood cells. The presence of this size variation prompts a deeper medical investigation to locate the root cause.

The clinical value of this finding lies entirely in the underlying pathology it represents, which can range from an easily correctable nutritional deficiency to complex bone marrow disorders like myelodysplastic syndrome or liver disease.

Therefore, medical treatment is never directed at “curing” the anisocytosis itself. Instead, therapies are tailored to resolve the primary diagnosis. Once the underlying disease is effectively managed, the bone marrow resumes the orderly production of uniform red blood cells, naturally resolving the anisocytosis.

The Diagnostic Nuances and Related Conditions of Anisocytosis

The diagnostic nuances of anisocytosis involve analyzing specific blood metrics like Red Cell Distribution Width (RDW), classifying the types of size variation, and distinguishing it from related red blood cell abnormalities like poikilocytosis. Furthermore, understanding these details is crucial because treatment is not aimed at anisocytosis itself but at the specific underlying condition causing the red blood cell size discrepancy.

By examining the complete blood count (CBC) report and peripheral blood smear, clinicians can uncover the root cause, from simple nutritional deficiencies to more complex chronic diseases, and devise an appropriate therapeutic strategy.

1. Comprehensive Laboratory Assessment: The Interplay of RDW, MCV, and Reticulocytes

To fully uncover the meaning behind an anisocytosis abnormal finding, clinicians cannot look at the Red Cell Distribution Width (RDW) in isolation. Instead, they must evaluate it as part of a broader diagnostic triad that includes the Mean Corpuscular Volume (MCV) and the Reticulocyte Count. Together, these metrics map out both the physical traits of the circulating red blood cells and the real-time activity of the bone marrow.

                     [The Complete Erythrocyte Diagnostic Triad]
                                         │
       ┌─────────────────────────────────┼─────────────────────────────────┐
       ▼                                 ▼                                 ▼
[Red Cell Distribution Width]     [Mean Corpuscular Volume]         [Reticulocyte Count %]
- Measures size heterogeneity     - Calculates average volume       - Measures new cell output
- Formally flags anisocytosis     - Groups into micro/macro/normo   - Shows marrow responsiveness

The Reticulocyte Count: Assessing Bone Marrow Activity

Reticulocytes are immature, newly formed red blood cells that still contain remnants of ribosomal RNA. They typically spend about one day maturing in the bone marrow before being released into circulation, where they fully mature within 24 to 48 hours. A normal reticulocyte count sits between 0.5% and 2.5% of the total red blood cell population.

When a blood test shows an anisocytosis abnormal result, checking the reticulocyte count helps determine how the bone marrow is responding:

Elevated Reticulocyte Count (Hyperproliferative State): An elevated reticulocyte count paired with a high RDW indicates that the bone marrow is rapidly pushing out new cells to compensate for an acute problem, such as sudden blood loss or active hemolysis (premature cell destruction). Because these youthful reticulocytes are physically larger than fully mature red blood cells, their sudden arrival into the bloodstream creates a mixed population, raising the RDW.

Low or Normal Reticulocyte Count (Hypoproliferative State): Conversely, a low or normal reticulocyte count alongside significant anisocytosis points to a foundational production problem. It shows that despite a systemic shortage of functional red blood cells, the bone marrow cannot step up production. This pattern is characteristic of nutrient deficiencies (like severe iron, B12, or folate depletion) or underlying bone marrow diseases, such as myelodysplastic syndrome or aplastic anemia.

2. Advanced Microscopic Analysis: Sorting Out Size vs. Shape

While automated hematology analyzers provide precise numbers for MCV and RDW, verifying a complex case of anisocytosis abnormal requires a manual review of a peripheral blood smear under a microscope. This visual assessment allows a pathologist to examine structural variations that automated machines might misinterpret.

                           [Peripheral Blood Smear View]
                                         │
       ┌─────────────────────────────────┴─────────────────────────────────┐
       ▼                                                                   ▼
[Anisocytosis: Size Evaluation]                     [Poikilocytosis: Shape Analysis]
- Identifies Microcytes (diameter < 6 µm)           - Identifies Schistocytes (mechanical tearing)
- Identifies Macrocytes (diameter > 8.5 µm)         - Identifies Spherocytes (membrane loss)
- Exposes dimorphic, multi-generational splits       - Identifies Target Cells (excess membrane surface)

Pathological Identification of Cell Sizes

Under the microscope, a pathologist compares the patient’s red blood cells to the nucleus of a normal small lymphocyte, which serves as a helpful visual reference point (roughly 8 micrometers).

• Microcytes: Cells with a diameter under 6 micrometers and a widened central pale area (hypochromia), indicating a severe lack of hemoglobin.

• Macrocytes: Cells with a diameter over 8.5 micrometers. Oval-shaped macrocytes (macroovalocytes) are a classic sign of a megaloblastic process caused by B12 or folate deficiencies.

The Diagnostic Value of Specific Cell Shapes (Poikilocytosis)

When an anisocytosis meaning is accompanied by changes in cell shape (poikilocytosis), the specific shapes observed can point directly to an underlying cause:

Schistocytes (Fragmented Cells): These are broken pieces of red blood cells with sharp angles and helmet-like shapes. Seeing schistocytes alongside size variations indicates mechanical destruction, often caused by blood cells squeezing through fibrin webs in damaged small vessels. This is a hallmark of serious conditions like Microangiopathic Hemolytic Anemia (MAHA) or Disseminated Intravascular Coagulation (DIC).

Spherocytes: These are cells that have lost their normal biconcave shape, appearing as small, dark spheres without a pale center. They occur when a portion of the cell membrane is removed, usually by macrophages in the spleen during autoimmune hemolytic anemia, or due to inherited genetic defects like hereditary spherocytosis.

Target Cells (Codocytes): These cells look like a bullseye because they have a central spot of hemoglobin surrounded by a clear ring and an outer colored rim. This shape occurs when there is an excess of cell membrane relative to the internal hemoglobin content. It is a key indicator of hemoglobin production issues, such as thalassemia, or lipid imbalances from advanced liver disease.

3. Pathophysiology of Nutrient Deficiencies: Cellular Disruption Mechanics

Nutritional deficiencies cause anisocytosis abnormal findings by disrupting the delicate, multi-step process of cell development in the bone marrow. The two main types—iron deficiency and megaloblastic states—alter cell structure through entirely different biological pathways.

                          [Nutrient Deficiency Mechanics]
                                         │
       ┌─────────────────────────────────┴─────────────────────────────────┐
       ▼                                                                   ▼
[Iron Depletion Pathway]                            [B12 / Folate Depletion Pathway]
- Lack of heme limits hemoglobin assembly           - Impaired purine synthesis stops DNA replication
- Precursor cells undergo an extra cell division   - Nucleus fails to split while cytoplasm expands
- Results in small, unevenly filled microcytes      - Results in oversized, fragile macroovalocytes

The Biology of Iron Deficiency Anemia

During normal cell development, erythroblasts synthesize hemoglobin continuously. When iron levels are depleted, the assembly of the heme group stops, slowing down hemoglobin production.

To adapt to this low level of hemoglobin, the developing cell undergoes an extra division cycle in the bone marrow. This extra split results in smaller cells (microcytes).

Because this deficiency develops gradually over weeks or months, the bone marrow releases an uneven mix of cells into the bloodstream. Older, normal-sized cells circulate alongside newly produced, tiny microcytes. This multi-generational mixture causes a high RDW.

The Biology of Vitamin B12 and Folate Deficiencies

Vitamin B12 and folate act as critical cofactors in the synthesis of thymidine triphosphate, a necessary building block for DNA replication. When either nutrient is missing, DNA synthesis slows down, while RNA production and protein synthesis in the cytoplasm continue as normal.

This mismatch leads to nuclear-cytoplasmic asynchrony. The cell’s nucleus cannot replicate its DNA to trigger a normal cell division, but the surrounding cytoplasm continues to grow.

The result is an oversized cell called a megaloblast. When these cells eventually enter circulation as macrocytes, they are physically larger, possess fragile membranes, and have a shortened lifespan, leading to their premature destruction in the spleen.

Conclusion

Anisocytosis can be a useful warning sign because it shows that red blood cells vary more in size than they should. Common causes include iron deficiency, vitamin B12 deficiency, folate deficiency, blood loss, hemolytic anemia, chronic disease, and bone marrow disorders. Still, anisocytosis should never be interpreted alone because it needs to be reviewed alongside other blood test results and symptoms. If a blood test shows anisocytosis, a healthcare provider can help determine the underlying cause and recommend the right next steps.

Read more: 10 Things to Know About Anisometropia and Unequal Vision

Frequently Asked Questions

1. What is anisocytosis?

Anisocytosis means there is more variation than usual in the size of red blood cells. Some cells may be too small, while others may be larger than normal. It is usually found during a complete blood count or by looking at a blood smear. Anisocytosis is not a diagnosis by itself, but it can point toward anemia or another blood-related condition.

2. What causes anisocytosis?

Anisocytosis can be caused by several conditions that affect red blood cell production or survival. Common causes include iron deficiency anemia, vitamin B12 deficiency, folate deficiency, recent blood loss, hemolytic anemia, and chronic inflammation. It may also appear in certain bone marrow disorders or after treatment for anemia. The exact cause depends on other lab results and the person’s medical history.

3. How is anisocytosis found on a blood test?

Anisocytosis may be suggested by a high red cell distribution width, also called RDW. RDW measures how much red blood cells vary in size. A blood smear can also show whether the cells are uneven, small, large, or mixed in appearance. Doctors usually compare RDW with hemoglobin, MCV, iron levels, vitamin B12, and folate to understand the pattern.

4. Does anisocytosis always mean anemia?

No, anisocytosis does not always mean a person has anemia. However, it is often seen in different types of anemia because red blood cell size can change when the body lacks iron, vitamin B12, or folate. Some people may show anisocytosis before anemia becomes severe or obvious. A healthcare provider will review the full blood count to see whether anemia is present.

5. How is anisocytosis treated?

Treatment for anisocytosis depends on what is causing the red blood cells to vary in size. If iron deficiency is the cause, treatment may include iron replacement and finding the reason for low iron. If vitamin B12 or folate deficiency is involved, supplements or dietary changes may be recommended. When anisocytosis is related to chronic disease or bone marrow problems, treatment focuses on managing the underlying condition.

Sources

• Anisocytosis: Causes, Meaning & Treatment (Cleveland Clinic)
• RDW Blood Test: What It Is, Procedure & Results (Cleveland Clinic)
• RDW (Red Cell Distribution Width) – MedlinePlus Medical Test
• Anemia (MedlinePlus)
• Red Cell Indices – Clinical Methods (NCBI Bookshelf)
• Peripheral Blood Smear – Clinical Methods (NCBI Bookshelf)
• Normal and Abnormal Complete Blood Count With Differential (NCBI Bookshelf)